Cantargia AB (publ) (STO:CANTA)
1.289
+0.009 (0.70%)
Nov 20, 2026, 5:29 PM CET
Cantargia AB Revenue
Cantargia AB had revenue of 95.00K SEK in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to 317.31M. In the year 2025, Cantargia AB had annual revenue of 316.70M. That makes Cantargia AB the 31,197th largest company in the world by revenue and 404th in Sweden.
Revenue (ttm)
317.31M
Revenue Growth
n/a
P/S Ratio
1.15
Revenue / Employee
14.42M
Employees
22
Market Cap
363.43M
Revenue by Geography
- Japan 308.69M 97.5%
- United States of America (USA) 8.01M 2.5%
Fiscal year ended Dec 31, 2025 See the full Cantargia AB breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 316.70M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sprint Bioscience AB | 134.13M |
| Xbrane Biopharma AB | 127.95M |
| Oncopeptides AB | 103.50M |
| Intervacc AB | 18.44M |
| Corline Biomedical AB | 12.63M |
| Medivir AB | 8.51M |
| Xspray Pharma AB | 7.19M |
| FluoGuide | 404.33K |
Cantargia AB News
- 12 days ago - Cantargia AB Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 17 days ago - Cantargia AB Transcript: BioStock Life Science Summit 2026 - Transcripts
- 2 months ago - Cantargia AB Transcript: Investing in Life Science 2026 - Transcripts
- 2 months ago - Cantargia AB Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 2 months ago - Cantargia AB Slides: H.C. Wainwright 28th Annual Global Investment Conference - Filings
- 3 months ago - Cantargia AB Earnings Call Transcript: Q2 2026 - Transcripts
- 3 months ago - Cantargia AB Quarterly report: Q2 2026 - Filings
- 3 months ago - Cantargia AB Slides: Q2 2026 - Filings